Mild cognitive impairment—an early stage of dementia—is widely underdiagnosed in people 65 and older. That is the key takeaway of two recent studies from our team.
Mar 24, 2024
0
408
A new Viewpoint article published in the Journal of the American Medical Association (JAMA), titled " Use of Lecanemab for Patients with Cardiovascular Disease—The Challenge of Uncertainty," advocates for additional research ...
Mar 18, 2024
0
1
On Jan. 31, aducanumab, a pricey drug approved for treatment of early-stage Alzheimer's disease, was withdrawn from the market. And in early March, the Food and Drug Administration delayed its decision regarding whether to ...
Mar 14, 2024
0
0
Monitoring daily activity patterns using a wrist-worn device may detect early warning signs of Alzheimer's disease, according to a recent study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
Mar 11, 2024
0
0
Early stages of neurodegenerative disorders are characterized by the accumulation of proteins in discrete populations of brain cells and the degeneration of these cells. For most diseases, this selective vulnerability pattern ...
Mar 11, 2024
0
2
Instead of approving the new Alzheimer's drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinized more closely by an expert panel, the drug's ...
Mar 8, 2024
0
0
Eli Lilly's highly anticipated Alzheimer's drug has been held back for further review by regulators, the US pharmaceutical giant said Friday, in a blow for patients with the devastating brain disorder.
Mar 8, 2024
0
10
New research suggests there is a link between abnormal blood levels of amyloid—a protein associated with Alzheimer's disease—and subtle changes in brain microstructures on a type of MRI, findings that could lead to a ...
Mar 6, 2024
0
45
Cerebrospinal fluid (CSF) and other biomarkers differ for individuals with Alzheimer disease and cognitively normal controls, with the estimated times of divergence varying from 18 to six years before diagnosis, according ...
Mar 2, 2024
0
45
A University of Kansas study of rare gene mutations that cause hereditary Alzheimer's disease shows these mutations disrupt the production of a small sticky protein called amyloid.
Feb 29, 2024
0
67
